Translating published and local evidence into pharmaceutical policy for early Alzheimer's disease: An evaluation of criteria for classifying patients as proven to 'benefit' in assessment-based drug-coverage.
Translating published and local evidence into pharmaceutical policy for early Alzheimer's disease: An evaluation of criteria for classifying patients as proven to 'benefit' in assessment-based drug-coverage.